Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in memory (CDw29-high) cerebrospinal fluid cells from acute MS patients.

M G Marrosu1

  • 1Institute of Infant Neuropsychiatry, Cagliari University, Italy.

Acta Neurologica Scandinavica
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Event-related potentials and deep grey matter atrophy in multiple sclerosis: Exploring the possible associations with cognition.

Multiple sclerosis and related disorders·2021
Same author

Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.

BMC neurology·2018
Same author

Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study.

Multiple sclerosis and related disorders·2018
Same author

Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment.

European journal of neurology·2018
Same author

Adult brain volume in multiple sclerosis: The impact of paediatric onset.

Multiple sclerosis and related disorders·2018
Same author

Cognition in multiple sclerosis: Between cognitive reserve and brain volume.

Journal of the neurological sciences·2018
Same journal

Editorial.

Acta neurologica Scandinavica·2022
Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022
Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022
Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022
Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022
Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022
See all related articles

In acute multiple sclerosis (MS), researchers observed a decrease in memory T-cells (CDw29+). This suggests that changes in CDw29+ cells may contribute to the development of acute MS attacks.

Area of Science:

  • Immunology
  • Neuroscience
  • Cell Biology

Background:

  • CD45R (2H4) and CDw29 (4B4) molecules are crucial for regulating immunological memory.
  • CD45R identifies naive T-cells, while CDw29 identifies activated memory T-cells.

Purpose of the Study:

  • To investigate the role of CD45R and CDw29 molecules in multiple sclerosis (MS).
  • To analyze T-cell subsets in the cerebrospinal fluid (CSF) of patients with acute MS, stable MS, and other neurological diseases.

Main Methods:

  • Two-color fluorescence analysis was used to study T-cell subsets (CD4, CD8, CD45R, CDw29) in CSF.
  • Patient groups included acute MS (MSa), stable MS (MSs), and patients with other non-inflammatory neurological diseases (OND).

Main Results:

Related Experiment Videos

  • Acute MS patients (MSa) showed a higher percentage of CD4+CD29-, CD4+CD45R-, and CD8+CD45R- cells compared to OND and MSs groups.
  • A decreased percentage of CD4-CDw29+ and CD8-CDw29+ cells was observed in MSa patients.

Conclusions:

  • The findings suggest a reduction in memory T-cells (CDw29+) during the acute phase of MS.
  • Modulation of the CDw29 receptor may be implicated in the pathogenesis of acute MS relapses.